Tag Archive: h2020

  1. Online ePanel discussion and SciTalk presentations on HIV research with EAVI2020 partners

    Leave a Comment

    The eAccess Meetings project

    In 2016, The Global HIV Vaccine Enterprise and Keystone Symposia inaugurated a collaboration to produce an ePanel discussion and series of SciTalks presentations that brought together key experts in the HIV prevention vaccine field.

    Following the great response to the inaugural video series, to which EAVI2020 also contributed with two presentations, the Global HIV Vaccine Enterprise in collaboration with Keystone Symposia has now presented the second series of eAccess Meetings: 2017 Keystone Symposia on HIV Vaccines.

    EAVI2020’s participates in an ePanel discussion and SciTalks presentations

    As part of the eAccess Meetings project, EAVI2020 participated in an ePanel discussion on Antibody Functions Beyond Neutralization with Prof Robin Shattock as a panellist (Imperial College) and Dr Gabriella Scarlatti (Global HIV Vaccine Enterprise) as moderator.

    The ePanel discussion is available online and can be found on the Enterprise web portal or on their YouTube Channel playlist.

    screenshots of TV frame of Gabriella Scarlatti and Robin Shattock

    Additionally, Gunilla Karlsson Hedestam and Paola Martinez Murillo (Karolinska Institutet) also participated in the SciTalks with presentations on “Individualized profiling of germline antibody V genes” and “F9, a new class of antibodies that neutralizes autologous tier 2 viruses in NHP immunized with liposome conjugated well-ordered trimers”.

    SciTalks can also be accessed on the Enterprise web portal or on their YouTube Channel playlist.

    screenshots of TV frames of Gunilla Karlsson Hedestam and Paola Martinez-Murillo

     

    More information

    eAccess Meetings: 2017 Keystone Symposia on HIV Vaccines.

    For more information about EAVI2020, please contact us.

  2. EAVI2020’s third course on HIV immunology and vaccines

    Leave a Comment

    On 23-26 April 2017, EAVI2020 celebrated its Third PhD course on HIV immunology and vaccines.

    The course was organised by project partners Karolinska Institutet and Fundació Clinic per a la Recerca Biomèdica and took place at Karolinska Institutet, Stockholm.

    The topics that were discussed included How to write a grant application,  how to be involved in  Responsible research and innovation activities,  examples of humanitarian action beyond the bench and after PhD, how to transmit the scientific results to the general population and of course scientific issues focuses on  HIV vaccines immunology. The course also included a Workshop on hepatitis, cancer vaccines and adjuvants.

    The students were enthusiastic and motivated active participants, which contributed to making a success of the course!

    More information

    For more information about EAVI2020 and our training courses, please contact us.

  3. EAVI2020 at the Keystone Symposia on HIV vaccines, 26-31 March 2017

    Leave a Comment

    EAVI2020’s partner institutions presented the latest research on HIV vaccines at the Keystone Symposia on HIV vaccines.

    As part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation, the HIV vaccines series took place on the 26-31 March 2017 in Colorado, USA.

    Despite great progress in preventing and treating HIV, new infections continue to plague communities around the world, and the need for an HIV vaccine is as urgent as ever. Several large cohorts of HIV-infected individuals have enabled tremendous advances over the past five years in understanding immune responses to natural HIV infection. These advances have included the isolation of broad and potent anti-HIV antibodies, defining their developmental pathways, the generation of native-like Env trimers for immunization, and high-resolution structures of the envelope glycoprotein in complex with bnAbs. By 2017, many of these discoveries will have enabled new concepts to transition into human clinical trials, including passive monoclonal antibody therapy and novel immunization approaches. These platforms, incorporating improved technology for monitoring immune responses, will drive major advances in the vaccine field. This HIV Vaccines meeting will present the latest results from human clinical studies, along with the cutting-edge basic science behind such trials to highlight approaches that may lead to an HIV vaccine, and also reveal the molecular underpinnings of B and T cell-mediated immunity.

    EAVI2020 at the Keystone Symposia

    EAVI2020 partners gave presentations on the latest research developments under EAVI2020 on topics like DNA Vaccination for Experimental Medicine Trials of HIV Vaccines (R. Shattock, Imperial), Inducing HIV-1 Neutralizing Antibodies with Native-Like Envelope Trimers (R. Sanders, AMC), Individualized Profiling of Germline V Genes and Application to Env Trimer Immunogenicity Studies in NHPs (G. Karlsson Hedestam, Karolinska Institutet) and ADCC and Beyond (S. Kent, University of Melbourne).

    EAVI2020’s PhD student Yoann Aldon also gave a poster presentation on HIV vaccines management.

    More information

    Full programme and for more information on the Keystone Symposia on HIV vaccines.

    For more information about EAVI2020, please contact us.

    Gunilla Karlsson Hedestam talking in front of a digital projection Rogier Sanders talking behind a lectern

    G. Karlsson Hedestam and R. Sanders.
  4. Presentations from EAVI2020 partners at the 2016 Keystone Symposia on HIV Vaccines are available online!

    Leave a Comment

    The Global HIV Vaccine Enterprise in collaboration with Keystone Symposia organized an ePanel discussion and series of SciTalks presentations that brought together key experts in the HIV prevention vaccine field.

    The ePanel and SciTalks addressed a broad range of topics pertinent to state-of-the-art HIV vaccine research. As part of the Global HIV Vaccine Enterprise eAccess Meetings initiative, videos of several presentations recorded onsite at the 2016 Keystone Symposia on HIV Vaccines are available.


    EAVI2020 – present at the 2016 Keystone Symposia on HIV Vaccines

    The Keystone Symposia highlighted cutting-edge scientific developments and challenges in the field in 90-minute sessions that included SciTalk presentations by EAVI2020 Partners:

    Professor Tomas Hanke, from the University of Oxford, presented “A novel conserved-region T-cell mosaic vaccine with very high global coverage of HIV-1 variants is recognized by protective responses in chronic untreated infection” and his presentation is available as a webcast.

    Dr Marit van Gils, from Academisch Medisch Centrum, received the New Investigator Award at HIVR4P and presented “A broadly neutralizing antibody from an elite neutralizer, targets a novel site at the gp120-gp41 interface”. Her presentation is available as a webcast.

    More information

    eAccess Meetings past presentations.
    For more information about EAVI2020, please contact us.

  5. 2nd Phd training course, Barcelona, 9 Nov 2016

    Leave a Comment

    Fundació Clínic per a la Recerca Biomèdica and Karolinska Institutet organised the Second course on HIV immunology and vaccines in Barcelona, 9th November 2016.

    Twenty four students from all over Europe joined this advanced training session on HIV immunology and vaccines for top PhD students across Europe hosted by the School of Medicine, University of Barcelona.

    EAVI2020 principal investigators lead the presentations and discussions and, as part of the training, PhD students prepared poster presentations, which were displayed for over 70 people at the EAVI2020 first annual meeting on the 10th and 11th November 2016.

    students sitting in a lecture room two men in lab coats talking to a room of students Tomas Hanke talking to students in a lecture room Joseph Munne talking to a lecture room of students

    For more information about EAVI2020, please contact us.

     

  6. EAVI2020 at the “Toolkits for DNA vaccine design, an update” conference in Moscow

    Leave a Comment

    17-21 November 2016

    Dr Joan Joseph from Fundació Clínic per a la Recerca Biomèdica presented lessons learned on “Pre-clinical development of recombinant BCG based HIV vaccine” at the event, which took place at the Mechninov´s Institute of Vaccine and Sera in Moscow from the 17th to 21st November 2016.

    The conference covered the whole area of DNA vaccine design starting from gene design, defining of transcription and translation signals, packaging, delivery, induction of innate immune response and role of adjuvants, induction and expansion of adaptive immune response, prime and boost strategies, success of DNA vaccines in cancer and infectious diseases, comparison of DNA vaccines to other vaccine modalities.

    Representatives of R&D companies and state agencies involved in the development, production and distribution of vaccines were also invited to discuss the business models for DNA vaccines, public perception of the vaccines and their perspectives for human and veterinarian use.

    More information on the International Conference “Toolkits for DNA vaccine design, an update”.

  7. EAVI2020’s first year of research!

    Leave a Comment

    Coinciding with the project’s one year anniversary, we are excited to publish the fourth issue of the EAVI2020 Newsletter!

    In this issue we have covered our upcoming EAVI2020 first annual meeting and 2nd PhD course on HIV vaccines and immunology.

    You can also find links to international HIV related papers and a list of upcoming events where you will find us.

    Sign-up to receive EAVI2020’s quarterly Newsletter and find out about the latest project developments as they arise!

    The EAVI2020 team at work this past year!:

    Robin Shattock speaking at a lectern in a large glass room with peopleGabriella Scarlatti and Philip Mundsperger smiling in a room of people, next to a sign for the Vaccine Manufacturing Workshop   Marit van Gils standing at a HIVR4P deskJoseph Munne on stage presenting an EAVI2020 seminar Anna Janna Behrens on stage at a lectern presenting at a conferencepeople sitting at rectangle tables engaged in conversation